Literature DB >> 21443714

Ghrelin family of peptides and gut motility.

Akihiro Asakawa1, Koji Ataka, Kazunori Fujino, Chih-Yen Chen, Ikuo Kato, Mineko Fujimiya, Akio Inui.   

Abstract

Acyl ghrelin, des-acyl ghrelin, and obestatin are three peptides isolated from the gastrointestinal tract and encoded by the same preproghrelin gene. Three ghrelin gene products participate in modulating appetite, adipogenesis, glucose metabolism, cell proliferation, immune, sleep, memory, anxiety, cognition, and stress. We have investigated the effects of ghrelin family of peptides on fed and fasted motor activities in the stomach and duodenum of freely moving conscious rats by manometric method. Intracerebroventricular (ICV) and intravenous (IV) administration of acyl ghrelin induced fasted motor activity in the duodenum in fed rats. ICV and IV administration of des-acyl ghrelin disrupted fasted motor activity in the antrum. Changes in gastric motility induced by IV administration of des-acyl ghrelin were antagonized by ICV administration of a corticotropin-releasing factor (CRF) 2 receptor antagonist. IV administration of obestatin decreased the percentage motor index in the antrum and prolonged the time taken to return to fasted motility in the duodenum in fed rats. ICV administration of CRF 1 and 2 receptor antagonists prevented the effects of obestatin on gastroduodenal motility. Ghrelin gene products regulate feeding-associated gastroduodenal motility. Stomach may regulate various functions including gastrointestinal motility via acyl ghrelin, des-acyl ghrelin and obestatin as an endocrine organ. Increasing knowledge of the effects of ghrelin family of peptides on gastrointestinal motility could lead to innovative new therapies for functional gastrointestinal disorders.
© 2011 Journal of Gastroenterology and Hepatology Foundation and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21443714     DOI: 10.1111/j.1440-1746.2011.06638.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  6 in total

Review 1.  Inflammation in irritable bowel syndrome: Myth or new treatment target?

Authors:  Emanuele Sinagra; Giancarlo Pompei; Giovanni Tomasello; Francesco Cappello; Gaetano Cristian Morreale; Georgios Amvrosiadis; Francesca Rossi; Attilio Ignazio Lo Monte; Aroldo Gabriele Rizzo; Dario Raimondo
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

Review 2.  Is irritable bowel syndrome an organic disorder?

Authors:  Magdy El-Salhy; Doris Gundersen; Odd Helge Gilja; Jan Gunnar Hatlebakk; Trygve Hausken
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

3.  Endocrine cells in the oxyntic mucosa of the stomach in patients with irritable bowel syndrome.

Authors:  Magdy El-Salhy; Odd Helge Gilja; Doris Gundersen; Trygve Hausken
Journal:  World J Gastrointest Endosc       Date:  2014-05-16

Review 4.  The role of ghrelin, salivary secretions, and dental care in eating disorders.

Authors:  Takakazu Yagi; Hirotaka Ueda; Haruka Amitani; Akihiro Asakawa; Shouichi Miyawaki; Akio Inui
Journal:  Nutrients       Date:  2012-08-13       Impact factor: 5.717

Review 5.  Diet in irritable bowel syndrome.

Authors:  Magdy El-Salhy; Doris Gundersen
Journal:  Nutr J       Date:  2015-04-14       Impact factor: 3.271

6.  Effect of dietary management on the gastric endocrine cells in patients with irritable bowel syndrome.

Authors:  T Mazzawi; T Hausken; D Gundersen; M El-Salhy
Journal:  Eur J Clin Nutr       Date:  2014-08-06       Impact factor: 4.016

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.